Assyro AI

Orange Book product · Brand (NDA)

TEKTURNA

ALISKIREN HEMIFUMARATE

Brand (NDA)NDA 210709DISCN NODEN PHARMA

At a glance

Nov 14, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 14, 2017

    8 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ALISKIREN HEMIFUMARATE

Strength

EQ 37.5MG BASE

Dosage form

CAPSULE, PELLET

Route

ORAL

TE code

Not listed

Application

NDA 210709

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.